Targeted cancer therapy may jeopardize the effectiveness of subsequent immunotherapy by reducing dendritic cell numbers and activation, according to study of mice and patient samples.

Colorectal tumor cells limit their DNA repair in response to a targeted therapy, giving them a greater chance to develop resistance to the drug.

Researchers describe ways to study how cancer cells evade therapies that harness the immune system.

The parasite that causes malaria has evolved to evade many of the drugs that researchers have developed to fight the tropical disease.

Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment.

Identifying microbes from Earth that can survive on spacecraft may help scientists eliminate them from future space missions and from searches for extraterrestrial life.

UC Berkeley researcher Michael Eisen says he will run for Senate in 2018.